272 related articles for article (PubMed ID: 29265097)
21. Early-onset facioscapulohumeral muscular dystrophy type 1 with some atypical features.
Dorobek M; van der Maarel SM; Lemmers RJ; Ryniewicz B; Kabzińska D; Frants RR; Gawel M; Walecki J; Hausmanowa-Petrusewicz I
J Child Neurol; 2015 Apr; 30(5):580-7. PubMed ID: 24717985
[TBL] [Abstract][Full Text] [Related]
22. Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype.
Puppo F; Dionnet E; Gaillard MC; Gaildrat P; Castro C; Vovan C; Bertaux K; Bernard R; Attarian S; Goto K; Nishino I; Hayashi Y; Magdinier F; Krahn M; Helmbacher F; Bartoli M; Lévy N
Hum Mutat; 2015 Apr; 36(4):443-53. PubMed ID: 25615407
[TBL] [Abstract][Full Text] [Related]
23. [Gene diagnosis of facioscapulohumeral muscular dystrophy].
Zhang JL; Shen DG; Zhou PK; Liu JW; Jia N; Liu H; Wang HB; Yang SX; Frants RR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):232-4. PubMed ID: 12778451
[TBL] [Abstract][Full Text] [Related]
24. Clinical and genetic analysis of Korean patients with facioscapulohumeral muscular dystrophy.
Ki CS; Lee ST; Kim KS; Kim JW; Hong YH; Sung JJ; Park KS; Lee KW
J Korean Med Sci; 2008 Dec; 23(6):959-63. PubMed ID: 19119436
[TBL] [Abstract][Full Text] [Related]
25. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
[TBL] [Abstract][Full Text] [Related]
26. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy].
Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163
[TBL] [Abstract][Full Text] [Related]
27. Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats.
Statland JM; Donlin-Smith CM; Tapscott SJ; Lemmers RJ; van der Maarel SM; Tawil R
Neurology; 2015 Dec; 85(24):2147-50. PubMed ID: 26561289
[TBL] [Abstract][Full Text] [Related]
28. Facioscapulohumeral muscular dystrophy.
Statland J; Tawil R
Neurol Clin; 2014 Aug; 32(3):721-8, ix. PubMed ID: 25037087
[TBL] [Abstract][Full Text] [Related]
29. [Facioscapulohumeral muscular dystrophy: Report of seven patients].
Cea G; Jiménez D
Rev Med Chil; 2015 Mar; 143(3):304-9. PubMed ID: 26005816
[TBL] [Abstract][Full Text] [Related]
30. Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy.
Winston J; Duerden L; Mort M; Frayling IM; Rogers MT; Upadhyaya M
Eur J Hum Genet; 2015 Jan; 23(1):67-71. PubMed ID: 24755953
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis of facioscapulohumeral muscular dystrophy.
Tupler R; Gabellini D
Cell Mol Life Sci; 2004 Mar; 61(5):557-566. PubMed ID: 15004695
[TBL] [Abstract][Full Text] [Related]
32. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
Upadhyaya M; Cooper DN
Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
[TBL] [Abstract][Full Text] [Related]
33. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
34. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy.
van Overveld PG; Lemmers RJ; Sandkuijl LA; Enthoven L; Winokur ST; Bakels F; Padberg GW; van Ommen GJ; Frants RR; van der Maarel SM
Nat Genet; 2003 Dec; 35(4):315-7. PubMed ID: 14634647
[TBL] [Abstract][Full Text] [Related]
35. Nanopore-based single molecule sequencing of the D4Z4 array responsible for facioscapulohumeral muscular dystrophy.
Mitsuhashi S; Nakagawa S; Takahashi Ueda M; Imanishi T; Frith MC; Mitsuhashi H
Sci Rep; 2017 Nov; 7(1):14789. PubMed ID: 29093467
[TBL] [Abstract][Full Text] [Related]
36. Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling.
Scionti I; Fabbri G; Fiorillo C; Ricci G; Greco F; D'Amico R; Termanini A; Vercelli L; Tomelleri G; Cao M; Santoro L; Percesepe A; Tupler R
J Med Genet; 2012 Mar; 49(3):171-8. PubMed ID: 22217918
[TBL] [Abstract][Full Text] [Related]
37. [Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].
Jordan B; Müller-Reible C; Zierz S
Nervenarzt; 2011 Jun; 82(6):712-22. PubMed ID: 21567298
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic features of somatic mosaicism in facioscapulohumeral dystrophy.
Qiu L; Ye Z; Lin L; Wang L; Lin X; He J; Lin F; Xu G; Cai N; Jin M; Chen H; Lin M; Wang N; Wang Z
J Med Genet; 2020 Nov; 57(11):777-785. PubMed ID: 32170003
[TBL] [Abstract][Full Text] [Related]
39. In junk we trust: repetitive DNA, epigenetics and facioscapulohumeral muscular dystrophy.
Neguembor MV; Gabellini D
Epigenomics; 2010 Apr; 2(2):271-87. PubMed ID: 22121874
[TBL] [Abstract][Full Text] [Related]
40. Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era.
Zampatti S; Colantoni L; Strafella C; Galota RM; Caputo V; Campoli G; Pagliaroli G; Carboni S; Mela J; Peconi C; Gambardella S; Cascella R; Giardina E
Neurogenetics; 2019 May; 20(2):57-64. PubMed ID: 30911870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
